Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cel symbols : NVSEF save search
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | $135.94 770
|
Health Technology
|
| O: -2.09%
H: 5.03%
C: 0.85%
ALPMY | $9.2715 500K
|
Manufacturing
|
| O: 1.01%
H: 0.81%
C: -0.06%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
ABBV | $163.42 1.08% 2M
|
Health Technology
|
| O: 0.29%
H: 0.6%
C: -1.24%
SNY | $46.05 -0.41% 940K
|
Health Technology
|
| O: 3.03%
H: 0.0%
C: 0.0%
AZN | $68.38 -0.51% 2.1M
|
Health Technology
|
| O: -0.44%
H: 0.0%
C: 0.0%
AMGN | $264.955 -0.21% 880K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
drug cel lung cancer cancer drug cancer growth
Cell Therapy Market 2022-2026 | Increasing Prevalence of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-03 (Crawled : 11:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: -0.06%
ALPMY | $9.2715 500K
|
Manufacturing
|
| O: -1.78%
H: 1.63%
C: 1.5%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
BCLI | $0.5325 -2.95% 500K
|
Health Technology
|
| O: -0.64%
H: 2.09%
C: -2.25%
disease cel therapy growth
Sickle Cell Disease Treatment Market size to Record 10.83% Y-O-Y Growth Rate in 2021 | Addmedica SAS and Bristol-Myers Squibb Co. are the leading companies in the market | Technavio
Published: 2022-02-08 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
CRSP | $58.46 -0.44% 670K
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
treatment disease cel growth
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
NVS | $92.99 -1.5% 990K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
JNJ | $145.405 -1.48% 7.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SRNE | $0.033 2M
|
Health Technology
|
| O: -5.96%
H: 0.0%
C: 0.0%
GILD | $67.44 -0.46% 2.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
BLUE | $1.015 -1.46% 1.9M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
cel therapy t-cell
Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report 2021: Analysis of Yescarta, Tecartus, Kymriah, Breyanzi, & Abecma
Published: 2021-12-24 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 82K
|
Health Technology
| Email alert
Add to watchlist
ABBV | $163.42 1.08% 2M
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.99 -1.5% 990K
|
Health Technology
| Email alert
Add to watchlist
CYAD | $0.47 -12.49% 49K
|
Health Technology
| Email alert
Add to watchlist
yescarta research kymriah cel therapy t-cell
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
WISA 4 | $5.33 204.57% 190M
|
Electronic Technology
TPET | $0.5189 124.54% 38M
|
n/a
SXTC | $1.78 52.14% 33M
|
Health Technology
JAGX | $0.1771 49.07% 540M
|
Health Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
FNCH | $2.98 32.74% 400K
|
Professional, Scientific, and T...
PALI | $5.51 32.45% 28M
|
Manufacturing
VERO | $0.804 31.8% 110K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.